ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.54
-0.09%
US Tech 100
19,220.00
-0.20%
S&P 500
5,464.62
-0.16%
US Dollar vs CAD
1.36995
0.00%
Bitcoin
64,375.41
0.20%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Annovis Bio Inc (ANVS)

  7. Annovis Bio Inc (ANVS) News

ANVS

Annovis Bio (ANVS)

Annovis Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ANVS
DateTimeSourceHeadlineSymbolCompany
06/13/20245:05AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
06/11/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
06/05/20243:32PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
05/21/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
05/21/20246:30AMGlobeNewswire Inc.Annovis Announces New Publication in a Peer-Reviewed JournalNYSE:ANVSAnnovis Bio Inc
05/13/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
05/13/20246:30AMGlobeNewswire Inc.Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial ResultsNYSE:ANVSAnnovis Bio Inc
05/10/20244:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ANVSAnnovis Bio Inc
05/09/20243:03PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
05/09/20246:30AMGlobeNewswire Inc.Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s DiseaseNYSE:ANVSAnnovis Bio Inc
05/06/20244:12PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:ANVSAnnovis Bio Inc
05/06/20244:11PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
05/06/20246:30AMGlobeNewswire Inc.Annovis Bio CEO Maria Maccecchini Issues Letter to StockholdersNYSE:ANVSAnnovis Bio Inc
04/29/20249:10AMGlobeNewswire Inc.Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s DiseaseNYSE:ANVSAnnovis Bio Inc
04/02/20246:30AMGlobeNewswire Inc.Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial ResultsNYSE:ANVSAnnovis Bio Inc
02/28/20246:08AMIH Market NewsUS Stock Movers Before Market: Beyond Meat, eBay, First Solar, Urban Outfitters…NYSE:ANVSAnnovis Bio Inc
02/12/20241:00PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NYSE:ANVSAnnovis Bio Inc
02/01/20243:05PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NYSE:ANVSAnnovis Bio Inc
11/22/20233:27PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
11/22/20233:24PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
11/22/20233:21PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
11/22/20233:14PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
11/21/20231:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
11/21/20231:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
11/21/20231:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
11/21/20231:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
11/08/20233:45PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ANVSAnnovis Bio Inc
11/02/20236:30AMBusiness WireAnnovis Bio Measures Novel Biomarkers in Plasma of Parkinson’s PatientsNYSE:ANVSAnnovis Bio Inc
11/01/202311:28AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
11/01/202311:24AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ANVSAnnovis Bio Inc
 Showing the most relevant articles for your search:NYSE:ANVS

Your Recent History

TG
BRCA
Brembo
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved